Skip to main content

Rhenman & Partners Asset Management AB

Position in CRL — Charles River Laboratories International, Inc.

CIK 1599882 Stockholm, V7

Position in CRL

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$4,485,000
+$96,440 QoQ
Shares Held
26,000
+18.2% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
8 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CRL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

Rhenman & Partners Asset Management AB holds $73,822,363 across 8 Diagnostics & Research names. CRL ranks #6 (6.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 CRL
Charles River Laboratories International, Inc.
This page
26,000 $4,485,000

All Filings in CRL

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,485,000 26,000
2025-12-31 $4,388,560 22,000
2024-12-31 $2,741,310 14,850
2024-09-30 $7,386,375 37,500
2024-06-30 $7,023,720 34,000
2024-03-31 $3,441,065 12,700
2023-12-31 $8,983,200 38,000
2023-09-30 $8,623,120 44,000